Increased IL-23 Levels in Psoriatic arthritis tied with Depression and Anxiety Dr. Shravani Dali4 Aug 2022 8:00 PM ISTIncreased IL-23 Levels in PsA Patients are tied with Depression and Anxiety according to a recent study published in the Clinical Rheumatology ...
Janssen gets USFDA nod for psoriatic arthritis treatment STELARA for pediatric patients Ruchika Sharma4 Aug 2022 11:46 AM ISTSTELARA is administered as a subcutaneous injection dosed four times per year after two starter doses for the treatment of pediatric patients six...
Swelling and not tenderness of joints better predicts synovitis in psoriatic arthritis Dr. Hiral patel30 Jun 2022 8:00 PM ISTUK: Swollen joints are the better proxy for ultrasound (US) synovitis as compared to tender joints in DMARD-naive early psoriatic arthritis (PsA)...
Systemic glucocorticoids use safe for patients with psoriasis: Study Dr. Hiral patel23 Jun 2022 7:30 PM ISTNetherlands: Systemic glucocorticoids (SGCs) exposure does not increase the risk of occurrence of psoriatic flares in psoriasis and psoriatic...
Janssen Pharma launches icare4u program for skin, joint, digestive disorders Ruchika Sharma22 May 2022 9:00 AM ISTMumbai: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the launch of icare4u, a comprehensive program to support the...
Long-term control of psoriasis may require several courses of different agents in some cases: JAMA Medha Baranwal20 April 2022 9:00 AM ISTLong-term control of psoriasis (PsO) and psoriatic arthritis (PsA) for some patients may require several courses of different agents, a recent study...
Methotrexate escalation or add on adalimumab- Trial guides selecting initial PsA treatment Medha Baranwal23 March 2022 9:45 AM ISTUK: Results from a phase 4, an open-label study supports the addition of tumor necrosis factor (TNF) inhibitor adalimumab over escalating methotrexate...
Dactylitis tied with higher disease burden in early psoriatic arthritis: BMJ Dr. Shravani Dali8 March 2022 9:00 AM ISTDactylitis signals greater disease burden in early psoriatic arthritis, according to a recent study published in the Annals of the Rheumatic ...
Sun Pharma gets CDSCO nod for Tofacitinib Roshni Dhar18 Feb 2022 5:32 PM ISTIn a significant development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted...
Health Bulletin 18/February/2022 Roshni Dhar18 Feb 2022 5:21 PM ISTHere are Top Health stories of the dayHacking: Anti-hijab tweet on doc's account Dr Shantanu R Prabhu, a pediatrician in Ujire, said in a...
Sun Pharma gets CDSCO nod to market Tofacitinib to treat Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis Susmita Roy17 Feb 2022 4:20 PM ISTNew Delhi: In a significant development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...
Continued ixekizumab therapy better than ixekizumab withdrawal in Psoriatic Arthritis patients MD Bureau2 Feb 2022 9:00 AM ISTThere are several disease-modifying antirheumatic drugs (DMARDs) available to patients with psoriatic arthritis (PsA), including conventional...
